Karyopharm Therapeutics
KPTI
KPTI
139 hedge funds and large institutions have $499M invested in Karyopharm Therapeutics in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
9% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 46
3% less funds holding
Funds holding: 143 → 139 (-4)
Holders
139
Holding in Top 10
1
Calls
$12M
Puts
$4.09M
Top Buyers
| 1 | +$40.2M | |
| 2 | +$26.2M | |
| 3 | +$14.7M | |
| 4 |
Morgan Stanley
New York
|
+$12.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.35M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$7.3M | |
| 3 | -$6.5M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$2.99M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.96M |